CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,117,307
- in 3 filings, $5.1M under 10b5-1 plans
Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-02 | Kumar Neil Director | Sale | −100 | $35.17 | $4K | 2,969,311 |
| 2020-01-02 | STEPHENSON BRIAN C | Sale | −2,295 | $32.57 | $75K | 367,621 |
| 2020-01-02 | STEPHENSON BRIAN C | Sale | −4,217 | $33.47 | $141K | 363,404 |
| 2020-01-02 | STEPHENSON BRIAN C | Sale | −622 | $34.23 | $21K | 362,782 |
| 2020-01-02 | STEPHENSON BRIAN C | Sale | −30 | $35.17 | $1K | 362,752 |
| 2020-01-01 | KKR Management Holdings L.P. 10% owner | Other disposition | −36,900,661 | 0 | ||
| 2019-12-30 | MCCORMICK FRANK Chairman of Oncology | Sale | −16,250 | $35.74 | $581K | 1,262,426 |
| 2019-12-30 | MCCORMICK FRANK Chairman of Oncology | Sale | −900 | $36.86 | $33K | 1,261,526 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −25,531 | $36.37 | $929K | 1,335,895 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −21,656 | $36.85 | $798K | 1,314,239 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −3,500 | $38.09 | $133K | 1,310,739 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −13,705 | $39.27 | $538K | 1,297,034 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −16,858 | $40.13 | $676K | 1,280,176 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −883 | $41.31 | $36K | 1,279,293 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −617 | $42.26 | $26K | 1,278,676 |
| 2019-12-27 | MCCORMICK FRANK Chairman of Oncology | Sale | −100 | $42.93 | $4K | 1,278,576 |
| 2019-12-12 | SCHELLER RICHARD H Director | Grant or award · Stock Option (right to buy) | +82,878 | 82,878 | ||
| 2019-12-12 | YAU YI CHING Chief Accounting Officer | Grant or award · Restricted Stock Units | +55,652 | 55,652 | ||
| 2019-12-12 | Stolz Brian M. Chief Operating Officer | Grant or award · Restricted Stock Units | +72,696 | 72,696 | ||
| 2019-12-12 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (right to buy) | +82,878 | 82,878 |
Page 56 of 61 · 1,201 trades